Budget Impact Models

Budget Impact Models

The RXA Budget Impact Model enables pharmaceutical companies to use the NHS’s own data to produce realistic and plausible cost saving prescribing switch strategies.

With the RXA Budget Impact model you can:

  • Create summary overviews at annual and portfolio levels
  • Drill down to underlying detailed product-specific calculations
  • Use tables, charts and maps in the purpose-built dashboard to provide extensive, highly visual and easy to interpret analytics
  • Make on the spot adjustments of model parameters – (E.g. switch %) via slider controls
  • Automatically rank the top ‘X’ GP practices to target
  • Create outputs to leave behind after meetings – Including CCG or GP practice level branded reports containing details of identified cost savings
We make analytics simple
Request your demonstration today

“The feature I like most? The ability to drill down to competitor sales.”

Senior Manager, Global Healthcare Company, 2016

“We chose Rx Analyser is because we wanted visibility of sales for our products. Rx Analyser is perfect for delivering a detailed level of data to practice level. The data is enabling us to set targets at territory level and assist our planning process as we can understand our competitor sales via Rx Analyser far better than previously.”

National Paediatric Manager, UK Health and Wellness Company

“Inspiremed are a pleasure to work with, blending both a solid understanding of software development and commercial experience.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“We are working in an ever evolving industry where data increasingly drives marketing and sales activity. I believe RX Analyser is the most comprehensive analytics tool available for prescription data analysis. I can already see other business areas (within my company) that could really benefit.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.”

Andrew Norman and David Warwick, Directors

“I am extremely happy with the model and with the working relationship we have with Inspiremed.”

Country Manager UK, Leading Diagnostics Company

Sign up for added insights